Early Access — free while we kick the tires
EdgarHawk

George Jeffrey P.

Director

Director

Latest: Director buying · March 2026

1 filing analyzed · 1 company · Latest 2026-03-30

Companies

Company Buys Sells Direction
LENZ Therapeutics, Inc. LENZ 1 0 Net buying

Activity

March 2026
high
Buy
5,592 shares
$49,890
Significance 6/10

Director George Jeffrey P. purchases 5,592 shares of LENZ at $8.92 as stock down 83.1% from 52-week high; cluster buy signals insider positioning

Director George Jeffrey P. purchased 5,592 shares at $8.92 on 2026-03-27, establishing an initial position in LENZ. The purchase occurs after a severe drawdown: the stock is trading at $8.29 (current price), representing an 83.1% decline from its 52-week high of $49.05, with a 30-day decline of 38.6% and 90-day decline of 48.6%. Notably, this transaction is part of a cluster pattern, with 2 other insiders also purchasing within the past 14 days, suggesting coordinated director-level positioning. Against this context, LENZ reports a loss-making fundamentals profile: net income of $-16.7M on quarterly revenue of $12.5M, with the company unprofitable over its full fiscal year, and a market cap of $259.9M. The convergence of multiple directors buying after sharp price deterioration warrants examination of whether this reflects strategic board-level confidence in the stock's depressed valuation or confidence in unannounced recovery catalysts.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access